July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The Ocular Hypertension Treatment Study: Aging and Reliability of Visual Fields
Author Affiliations & Notes
  • Mae O. Gordon
    Ophthal & Vis Sciences, Washington Univ Sch of Med, St Louis, Missouri, United States
  • Julia Huecker
    Ophthal & Vis Sciences, Washington Univ Sch of Med, St Louis, Missouri, United States
  • Kimberly Plumb
    Ophthalmology, University of California, Davis, Sacramento, California, United States
  • Laura Lemming
    Ophthalmology, University of California, Davis, Sacramento, California, United States
  • Michael A Kass
    Ophthal & Vis Sciences, Washington Univ Sch of Med, St Louis, Missouri, United States
  • John L Keltner
    Ophthalmology, University of California, Davis, Sacramento, California, United States
  • Michael Wall
    Neurology & Ophthalmology, Univ of Iowa, Iowa City, Iowa, United States
  • Chris A Johnson
    Ophthalmology, University of Iowa, Iowa City, Iowa, United States
  • Footnotes
    Commercial Relationships   Mae Gordon, None; Julia Huecker, None; Kimberly Plumb, None; Laura Lemming, None; Michael Kass, None; John Keltner, None; Michael Wall, None; Chris Johnson, None
  • Footnotes
    Support  Supported by NIH [EY025180, EY025181, EY025182 and EY025183]. Washington University Ophthalmology & Visual Sciences NIH/NEI Core Grant #P30EY002687. Washington University Ophthalmology & Visual Sciences Research to Prevent Blindness Unrestricted Grant. Clinical and Translational Science Award (CTSA) Grant [UL1 TR000448] and Siteman Comprehensive Cancer Center and NCI Cancer Center Support Grant P30 CA091842.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3025. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mae O. Gordon, Julia Huecker, Kimberly Plumb, Laura Lemming, Michael A Kass, John L Keltner, Michael Wall, Chris A Johnson; The Ocular Hypertension Treatment Study: Aging and Reliability of Visual Fields. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3025.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine if visual field reliability declines as participants age in the Ocular Hypertension Treatment Study (OHTS).

Methods : The OHTS enrolled 1,636 participants between 1994-1996. To be eligible, patients were required to have two normal, reliable Humphrey 30-2 full threshold VF’s in both eyes on baseline. In addition, VF technicians were required to be certified per protocol. The Visual Field Reading Center (VFRC) evaluated each VF for quality control using a 100-point scale. VF’s were completed every six months until close-out in 2009. In 2016, OHTS was funded to conduct a 20-year follow-up study to determine the quality of life and visual functioning of participants. VF testing protocol remained constant throughout the study.

We report the percent of participants with > 33% fixation loss at 12 years and at 22 years following baseline VF’s. One eye of each participant was selected randomly with preference given to the eye that developed primary open-angle glaucoma. We did not assess false positive or false negative rates because the algorithms changed during the study. Participants who returned for f/up but could not perform VF testing are assumed to have “excessive fixation losses” and are reported separately.

Results : To date, 47% (546 of 1,156) of the presumed survivors have completed VF testing. Twelve participants returned to the clinic but were unable to complete VF testing due to a physical/cognitive condition. The median time from baseline VF testing was 22 years.

The rate of excessive fixation losses was higher in each age decade older with sample size > 100. The rate of excessive fixation losses increased faster in older decades over the 22 year f/up.

Conclusions : The rate of excessive fixation loss was higher with older age in OHTS. The rate of fixation loss in OHTS likely underestimates the rate of fixation loss in a busy clinic secondary to our rigorous VF protocol requirements for patients and technicians, in addition to real-time quality monitoring by the VFRC.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×